
From October 27 to 28, the fourth edition of AI_4_LIFE: Biotech Future Forum will bring together leading experts from science, industry, and academia to explore how biotechnology and artificial intelligence are transforming healthcare, sustainability, and bioeconomy.
The program will feature Nobel Prize laureate Dr. Robert Huber, genetic research pioneer Dr. J. Craig Venter, as well as representatives from companies such as NVIDIA, IQVIA, and other global institutions. Over two days, participants will have the opportunity to attend keynote lectures, panels, and discussions on topics including AI-driven drug development, longevity, innovative medical devices, investments in biotechnology, tech transfer, and the future of clinical trials.
A special highlight will be the Serendipity Collective Challenge, a competition that brings together the most creative teams and their innovative ideas, with the winning project awarded up to USD 50,000.
Registration is now open on the official website of the conference – join the conversation about the future of biotechnology and artificial intelligence.